7 completed, 3 recruiting, 2 unknown, 1 active not recruiting. 5 Phase 1, 5 Phase 2, 1 Early Phase 1, 1 Not applicable, 1 Phase 4.
Follow Kidney Transplant: new trials by email Literature Review of Kidney Transplant trials Research Report on Kidney Transplant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| (TNX-1500) in Kidney Transplant Recipients TNX-1500, Kidney Transplant - Kidney Transplant, Kidney Transplant Failure and Rejection | Phase 2 | Not yet recruiting | Ayman Al Jurdi, MD | 5 | 2026-11-01 | 2026-08-19 |
| Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation Venetoclax, Hematopoietic Cell Transplantation Conditioning Regimen, Kidney Transplant - Kidney Failure Chronic, Stem Cell Transplant | Early Phase 1 | Recruiting | Massachusetts General Hospital | 3 | 2026-02-04 | 2026-10-14 |
| Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg - SIOD, Cystinosis | Phase 1 / Phase 2 | Recruiting | Alice Bertaina | 12 | 2023-01-10 | 2023-07-17 |
| Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors Kidney transplant - Human Immunodeficiency Virus, End Stage Renal Disease | Recruiting | Tulane University | 30 | 2021-11-15 | 2025-10-02 | |
| Evaluation of a Marine OXYgen Carrier for Organ Preservation Kidney transplant - End Stage Renal Diseases | Not applicable | Completed | University Hospital, Brest | 490 | 2020-07-04 | 2023-11-29 |
| Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review kidney transplant - Transplant, Kidney Diseases | Unknown | Methodist Health System | 240 | 2019-11-06 | 2024-11-20 | |
| Cell Therapy for Immunomodulation in Kidney Transplantation Regulatory T cells, Tocilizumab, Bone marrow - Kidney Transplantation | Phase 1 / Phase 2 | Active not recruiting | Thomas Wekerle | 12 | 2019-08-01 | 2026-09-11 |
| Minimally Invasive Kidney Transplantation kidney transplant - Transplant;Failure,Kidney | Unknown | Guy's and St Thomas' NHS Foundation Trust | 90 | 2017-12-01 | 2017-10-31 | |
| Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients Belatacept, Tacrolimus, Mycophenolate - Implant or Graft; Rejection | Phase 4 | Completed | Columbia University | 57 | 2014-06-01 | 2021-02-10 |
| Cognitive Impairment and Imaging Correlates in End Stage Renal Disease Kidney Transplant, No kidney transplant - End Stage Renal Disease | Completed | University of Kansas Medical Center | 120 | 2013-03-01 | 2024-10-09 | |
| SURGICAL EXPERIENCE ON RENAL TRANSPLANT COMPLICATIONS Kidney transplant - Kidney Transplant Failure | Completed | Centre Hospitalier Universitaire de Nice | 303 | 2013-01-01 | 2022-02-07 | |
| Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients Alemtuzumab, Mycophenolate mofetil, Sirolimus - Kidney Transplantation, Kidney Disease | Phase 1 / Phase 2 | Completed | University of Miami | 9 | 2004-09-01 | 2012-10-02 |
| Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults Alemtuzumab, Sirolimus, Tacrolimus - Kidney Transplantation, Kidney Disease | Phase 1 / Phase 2 | Completed | University of Wisconsin, Madison | 10 | 2003-11-01 | 2018-06-29 |
| Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD) Cyclophosphamide, anti-thymocyte globulin, Kidney transplant, Thymic irradiation - Multiple Myeloma, End Stage Renal Disease | Phase 1 | Completed | Massachusetts General Hospital | 10 | 2001-08-01 | 2020-03-04 |
Kidney Diseases (3) · Kidney Failure, Chronic (3) · Renal Insufficiency (3) · Rejection, Psychology (2) · Acquired Immunodeficiency Syndrome (1) · Bronchiolitis Obliterans Syndrome (1) · Cystinosis (1) · Delayed Graft Function (1) · Hematologic Neoplasms (1) · Lupus Nephritis (1) · Multiple Myeloma (1) · Renal Insufficiency, Chronic (1)
Massachusetts General Hospital (2) · Alice Bertaina (1) · Ayman Al Jurdi, MD (1) · Centre Hospitalier Universitaire de Nice (1) · Columbia University (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Methodist Health System (1) · Thomas Wekerle (1) · Tulane University (1) · University Hospital, Brest (1) · University of Kansas Medical Center (1) · University of Miami (1) · University of Wisconsin, Madison (1)
United States (10) · France (2) · Austria (1)
A. D'jamali, MD, MS (1) · Aditi Gupta, MD (1) · Alejandro Mejia, MD (1) · Alfred Luk, MD (1) · Alice Bertaina, MD (1) · Ayman Al Jurdi, MD (1) · George W. Burke, III, MD (1) · Mark A. Hardy, MD (1) · Nizam Mamode (1) · Paul Grimm, MD (1) · Thomas R Spitzer, MD (1) · Thomas Wekerle, MD (1)
PMID 23903014, PMID 26894920, PMID 33585521, PMID 37127632, PMID 38979743